Sports medicine market seen reaching $15.6B by 2035

Market Research Future projects the global sports medicine market will nearly double to $15.60 billion by 2035 from $7.72 billion in 2025, driven by rising sports injuries, minimally invasive procedures and the shift to ambulatory surgery centers. North America leads today, while Asia-Pacific is the fastest-growing region.

Why it matters: - The sports medicine market is moving from a specialty category into a broader orthopedic growth engine. - Demand is being pushed by more sports participation, more diagnosed injuries and more procedures shifting out of hospitals. - The market’s growth affects implants, arthroscopy tools, bracing, recovery monitoring and outpatient surgery economics.

What happened: - Market Research Future projected the global sports medicine market will reach USD 15.60 billion by 2035. - The market is forecast to rise from USD 7.72 billion in 2025 to USD 15.60 billion in 2035. - The forecast implies a 7.29% compound annual growth rate from 2026 through 2035. - The market entered the forecast window at USD 8.28 billion in 2026. - The report cited rising youth and amateur sports participation, minimally invasive techniques and ambulatory surgery center expansion as the main growth drivers. - The report included a sample request and full report links: Request a free sample and Read the detailed report.

The details: - Approximately 250,000 ACL injuries occur each year in the United States. - Youth sports participation among American children reached 39.8% in 2024, a five-year high. - Arthroscopic techniques, all-suture fixation, bioabsorbable anchors and biologic augmentation with platelet-rich plasma and collagen scaffolds are improving recovery and return-to-play timelines. - Migration of orthopedic procedures to ambulatory surgery centers is supported by reimbursement policy and is improving convenience and procedure economics. - Arthrex has committed more than USD 500 million to manufacturing and medical education infrastructure since 2022. - The U.S. Centers for Medicare & Medicaid Services expanded its Ambulatory Surgical Center Covered Procedures List to include total knee and partial hip arthroplasty. - European Union Medical Device Regulation recertification drove manufacturers to reinvest an estimated EUR 1.9 billion in clinical evidence generation between 2021 and 2025. - Orthopedic implants accounted for about 38.4% of market revenue in 2025. - Body monitoring and evaluation products are the fastest-growing product category at 10.15% CAGR. - Knee applications held the largest share at 32.7% in 2025. - Shoulder applications are growing at 8.15% annually. - Hospitals held 44.9% of end-use share in 2025. - Ambulatory surgical centers are the fastest-growing end user at 9.84% CAGR. - Direct sales remain the dominant distribution channel. - Online sales are the fastest-growing channel for bracing, compression and recovery products.

Between the lines: - The market is becoming less dependent on one-time implant sales and more tied to recurring consumables, education networks and recovery data. - All-suture anchors now account for an estimated 30% of shoulder fixation volume in high-income markets, showing how product design is shifting toward revision-friendliness and imaging compatibility. - The top five suppliers hold an estimated 52% to 58% of global revenue, which suggests a concentrated market with room for companies that control surgeon training and procedure workflows. - The report frames outpatient migration as a structural change, not a temporary reimbursement effect. - North America’s ASC density and payment differentials give it a major procedure-economics advantage, while Asia-Pacific’s growth reflects pricing pressure and manufacturing localization.

What's next: - The report expects expansion into emerging markets through local manufacturing and tiered pricing. - Biologic augmentation and sex-specific implant solutions are emerging opportunity areas. - Wearable-enabled recovery monitoring and outcome-linked commercial models are likely to gain traction through 2035. - Recovery data ownership may become a key competitive advantage in the next decade.

The bottom line: - Sports medicine is set for steady double-digit-scale dollar growth over the next decade, with the biggest gains likely coming from outpatient procedures, biologics and connected recovery tools.